Company Filing History:
Years Active: 1997-1999
Title: Innovations of Mike Heffernan in Serine/Threonine Kinase Research
Introduction
Mike Heffernan is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of molecular biology, particularly in the study of serine/threonine kinases. With a total of 2 patents, his work focuses on understanding the mechanisms of cell division.
Latest Patents
Heffernan's latest patents include innovative methods for identifying binding partners, agonists, and antagonists of a serine/threonine kinase protein. This protein is associated with mitotic and meiotic cell division and is characterized by having a kinase domain in its N-terminus and three PEST regions in the C-terminus. His patents also describe diagnostic and therapeutic methods using this serine/threonine kinase protein and the nucleic acid molecules encoding it.
Career Highlights
Mike Heffernan is affiliated with Mount Sinai Hospital Corporation, where he applies his expertise in research and development. His work has been instrumental in advancing the understanding of cell division processes, which has implications for various medical applications.
Collaborations
Heffernan collaborates with esteemed colleagues such as James W. Dennis and Carol Fode, contributing to a dynamic research environment that fosters innovation.
Conclusion
Mike Heffernan's contributions to the field of serine/threonine kinase research highlight his role as a significant inventor in molecular biology. His patents and collaborative efforts continue to pave the way for advancements in diagnostic and therapeutic methods.